Search research articles
Contact Us
Filters
Showing results (51-60 of 367) with videos related to
Page
of 37
Sort By:
JAMA
|
February 21, 1986
Clinical overlap among medical diagnosis-related groups
L I Iezzoni, M A Moskowitz
The American Journal of Medicine
|
May 1, 1988
Discharge decision-making in a medical intensive care unit. Identifying patients at high risk of unexpected death or unit readmission
H B Rubins, M A Moskowitz
Cephalalgia : an International Journal of Headache
|
September 1, 1991
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine
M G Buzzi, M A Moskowitz
JAMA
|
December 2, 1988
A clinical assessment of MedisGroups
L I Iezzoni, M A Moskowitz
Brain Research
|
October 29, 1993
Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater
W S Lee, M A Moskowitz
Stroke
|
November 1, 1981
Clinical applications of prostaglandins and their inhibitors
M A Moskowitz, S R Coughlin
Trends in Pharmacological Sciences
|
June 1, 1996
Emerging treatments for stroke in humans
W J Koroshetz, M A Moskowitz
Peptides
|
September 1, 1989
Identification of immunoreactive substance P in human and other mammalian endothelial cells
M D Linnik, M A Moskowitz
Clinics in Laboratory Medicine
|
June 1, 1986
Why office testing?
B E Statland, M A Moskowitz
Archives of Internal Medicine
|
August 1, 1991
Changes in physician attitudes toward limiting care of critically ill patients
R M Goetzler, M A Moskowitz
Page
of 37
Search research articles
Search
Showing results (51-60 of 367) with videos related to
Sort By:
Page
of 37
JAMA
|
February 21, 1986
Clinical overlap among medical diagnosis-related groups
L I Iezzoni, M A Moskowitz
The American Journal of Medicine
|
May 1, 1988
Discharge decision-making in a medical intensive care unit. Identifying patients at high risk of unexpected death or unit readmission
H B Rubins, M A Moskowitz
Cephalalgia : an International Journal of Headache
|
September 1, 1991
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine
M G Buzzi, M A Moskowitz
JAMA
|
December 2, 1988
A clinical assessment of MedisGroups
L I Iezzoni, M A Moskowitz
Brain Research
|
October 29, 1993
Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater
W S Lee, M A Moskowitz
Stroke
|
November 1, 1981
Clinical applications of prostaglandins and their inhibitors
M A Moskowitz, S R Coughlin
Trends in Pharmacological Sciences
|
June 1, 1996
Emerging treatments for stroke in humans
W J Koroshetz, M A Moskowitz
Peptides
|
September 1, 1989
Identification of immunoreactive substance P in human and other mammalian endothelial cells
M D Linnik, M A Moskowitz
Clinics in Laboratory Medicine
|
June 1, 1986
Why office testing?
B E Statland, M A Moskowitz
Archives of Internal Medicine
|
August 1, 1991
Changes in physician attitudes toward limiting care of critically ill patients
R M Goetzler, M A Moskowitz
Page
of 37